These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 32771187)

  • 1. Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Assis FR; Tandri H
    Card Electrophysiol Clin; 2020 Sep; 12(3):329-343. PubMed ID: 32771187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.
    Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F
    J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Gasperetti A; Tandri H
    Card Electrophysiol Clin; 2022 Dec; 14(4):679-683. PubMed ID: 36396184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.
    Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA
    Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Romero J; Patel K; Briceno D; Alviz I; Gabr M; Diaz JC; Trivedi C; Mohanty S; Della Rocca D; Al-Ahmad A; Yang R; Rios S; Cerna L; Du X; Tarantino N; Zhang XD; Lakkireddy D; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2022-2031. PubMed ID: 32478430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Road-Map to Epicardial Approach for Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Results From a 10-Year Tertiary-Center Experience.
    Bisceglia C; Limite LR; Baratto F; D'Angelo G; Cireddu M; Della Bella P
    Circ Arrhythm Electrophysiol; 2024 Jul; 17(7):e012181. PubMed ID: 38836351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
    Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
    Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia.
    Arbelo E; Josephson ME
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):473-86. PubMed ID: 20132399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.